Molecular mechanisms associated with the strength of the anti-CMV response in nonagenarians

Immunity and Ageing

Volumn 11, Issue 1, 2014, Pages

  Marttila, Saara ^a,b   Jylhävä, Juulia ^a,b   Kananen, Laura ^a,b   Hervonen, Antti ^a,b   Jylhä, Marja ^a,b   Hurme, Mikko ^a,b,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b Jyvaskyla University   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anti CMV IgG titre; Cytomegalovirus; Elderly; Immune response; Nonagenarians; Pathway analysis; Transcriptomics; Upstream regulator

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FUNCTIONAL DISEASE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; VERY ELDERLY;

EID: 84893198328     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-11-2     Document Type: Article

References (26)

1. Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012, 24:507-511. 10.1016/j.coi.2012.04.002, 22541724.
2. Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, McCann R, Menegus M, McCormick K, Frampton M, Hall W, Abraham GN. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999, 90:213-219. 10.1006/clim.1998.4638, 10080833.
3. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009, 155:423-432. 10.1111/j.1365-2249.2008.03785.x, 2669518, 19220832.
4. Derhovanessian E, Maier AB, Beck R, Jahn G, Hähnel K, Slagboom PE, de Craen AJM, Westendorp RGJ, Pawelec G. Hallmark features of immunosenescence are absent in familial longevity. J Immunol 2010, 185:4618-4624. 10.4049/jimmunol.1001629, 20855876.
5. Lachmann R, Bajwa M, Vita S, Smith H, Cheek E, Akbar A, Kern F. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol 2012, 86:1001-1009. 10.1128/JVI.00873-11, 3255847, 22072753.
6. Kuparinen T, Marttila S, Jylhävä J, Tserel L, Peterson P, Jylhä M, Hervonen A, Hurme M. Cytomegalovirus (CMV)-dependent and -independent changes in the aging of the human immune system: a transcriptomic analysis. Exp Gerontol 2013, 48:305-312. 10.1016/j.exger.2012.12.010, 23291591.
7. Strandberg TE, Pitkala KH, Tilvis RS. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301:380-382.
8. Roberts ET, Haan MN, Dowd JB, Aiello AE. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010, 172:363-371. 10.1093/aje/kwq177, 2950794, 20660122.
9. Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of cancer-norfolk cohort. Clin Infect Dis 2013, 56:1421-1427. 10.1093/cid/cit083, 3634310, 23442763.
10. Savva GM, Pachnio A, Kaul B, Morgan K, Huppert FA, Brayne C, Moss PA. Medical Research Council Cognitive Function and Ageing Study Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 2013, 13:381-387. Medical Research Council Cognitive Function and Ageing Study.
11. Haarala A, Kähönen M, Lehtimäki T, Aittoniemi J, Jylhävä J, Hutri-Kähönen N, Taittonen L, Laitinen T, Juonala M, Viikari J, Raitakari OT, Hurrme M. Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the cardiovascular risk in young Finns study. Clin Exp Immunol 2012, 167:309-316. 10.1111/j.1365-2249.2011.04513.x, 3278698, 22236008.
12. Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol 2010, 171:1144-1152. 10.1093/aje/kwq062, 2877470, 20400465.
13. Moro-García MA, Alonso-Arias R, López-Vázquez A, Suárez-García FM, Solano-Jaurrieta JJ, Baltar J, López-Larrea C. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age 2012, 34:479-495. 10.1007/s11357-011-9240-6, 3312637, 21487706.
14. Aiello AE, Haan MN, Pierce CM, Simanek AM, Liang J. Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci 2008, 63:610-618. 10.1093/gerona/63.6.610, 3178457, 18559636.
15. Matheï C, Vaes B, Wallemacq P, Degryse J. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort. J Am Geriatr Soc 2011, 59:2201-2208. 10.1111/j.1532-5415.2011.03719.x, 22092044.
16. Alonso Arias R, Moro-García MA, Echeverría A, Solano-Jaurrieta JJ, Suárez-García FM, López-Larrea C. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol 2013, 87:4486-4495. 10.1128/JVI.02425-12, 3624366, 23388717.
17. Li D, Zheng L, Jin L, Zhou Y, Li H, Fu J, Shi M, Du P, Wang L, Wu H, Chen GY, Zheng P, Liu Y, Wang FS, Wang S. CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection. Hepatology 2009, 50:735-742. 10.1002/hep.23047, 19610054.
18. Qi Y, Mao ZQ, Ruan Q, He R, Ma YP, Sun ZR, Ji YH, Huang Y. Human cytomegalovirus (HCMV) UL139 open reading frame: Sequence variants are clustered into three major genotypes. J Med Virol 2006, 78:517-522. 10.1002/jmv.20571, 16482559.
19. Yang SH, Sharrocks AD, Whitmarsh AJ. MAP kinase signalling cascades and transcriptional regulation. Gene 2013, 513:1-13. 10.1016/j.gene.2012.10.033, 23123731.
20. Moon JS, Lee MY, Park SW, Han WK, Hong SW, Ahn JH, Kim KS. Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells. Prostate 2008, 68:1450-1460. 10.1002/pros.20817, 18615458.
21. Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J Interferon Cytokine Res 2010, 30:555-564. 10.1089/jir.2010.0078, 2925029, 20712453.
22. Pagliaccetti NE, Robek MD. Interferon-λ the immune response to hepatitis B virus and hepatitis C virus. J Interferon Cytokine Res 2010, 30:585-590. 10.1089/jir.2010.0060, 2963630, 20645875.
23. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM, Diebold J, Diepolder H, Adler B, Auernhammer CJ, Göke B, Dambacher J. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005, 289:G960-G968. 10.1152/ajpgi.00126.2005, 16051921.
24. Goebeler S, Jylhä M, Hervonen A. Medical history, cognitive status and mobility at the age of 90: a population-based study in Tampere, Finland. Aging Clin Exp Res 2003, 15:154-161. 10.1007/BF03324494, 12889848.
25. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylhä M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci 2010, 65:658-663.
26. Kallio MA, Tuimala JT, Hupponen T, Klemelä P, Gentile M, Scheinin I, Koski M, Käki J, Korpelainen EI. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics 2011, 12:507. 10.1186/1471-2164-12-507, 3215701, 21999641.